CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanatani, Y.
Right arrow Articles by Honma, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanatani, Y.
Right arrow Articles by Honma, Y.

Cell Growth & Differentiation, Vol 7, Issue 2 187-196, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells

Y Kanatani, T Kasukabe, J Okabe-Kado, S Hayashi, Y Yamamoto-Yamaguchi, K Motoyoshi, N Nagata and Y Honma
Department of Chemotherapy, Saitama Cancer Center Research Institute, Japan.

Glucocorticoids inhibit the proliferation of lymphoid leukemia cells, whereas most myeloid leukemia cells are resistant to glucocorticoids. However, this study showed that glucocorticoids significantly and preferentially inhibited growth of monocytoid leukemia cells in combination with a low concentration of transforming growth factor beta (TGF beta). Combined 1 alpha,25-dihydroxyvitamin D3 and TGF beta markedly induced monocytic differentiation of U937 cells, whereas dexamethasone (Dex) and TGF beta essentially did not, although both combinations similarly inhibited the growth of U937 cells. The growth inhibition was accompanied by a block in the cell cycle progression from G1 to S phase (G1 arrest). Expression of glucocorticoid receptors was not affected by TGF beta, although they are induced during the monocytic differentiation of myelogenous leukemia cells and have increased sensitivity to glucocorticoids. The expression of TGF beta receptors also was not enhanced by Dex. TGF beta significantly stimulated glucocorticoid responsive element-mediated transcription activity. Combined Dex and TGF beta stimulated the expression of c-jun and c-fos early responsive genes in U937 cells, although Dex or TGF beta alone did not. The combination synergistically induced expression of c-jun gene, reaching a maximum level at 24 h. On the other hand, expression of c-fos gene was induced by TGF beta alone and increased additively in combination with Dex. Treatment with antisense oligonucleotide complementary to the first exon of c-jun mRNA reduced the growth-inhibitory effect of Dex and TGF beta in a dose-dependent manner. However, exposure of U937 cells to the sense oligomer of c-jun mRNA or an antisense oligomer of c-fos mRNA did not affect the growth inhibition. These results suggested that the preferential expression of c-jun and stimulation of glucocorticoid responsive element-mediated transactivation are closely associated with the growth arrest of U937 cells incubated with Dex and TGF beta.


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
Y.-X. Chen, Y. Wang, C.-C. Fu, F. Diao, L.-N. Song, Z.-B. Li, R. Yang, and J. Lu
Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells
Endocr. Relat. Cancer, January 29, 2010; 17(1): 39 - 50.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. Li, S. Wang, and T. D. Gelehrter
Identification of Glucocorticoid Receptor Domains Involved in Transrepression of Transforming Growth Factor-{beta} Action
J. Biol. Chem., October 24, 2003; 278(43): 41779 - 41788.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
L. M. Khachigian, R. G. Fahmy, G. Zhang, Y. V. Bobryshev, and A. Kaniaros
c-Jun Regulates Vascular Smooth Muscle Cell Growth and Neointima Formation after Arterial Injury: INHIBITION BY A NOVEL DNA ENZYME TARGETING c-Jun
J. Biol. Chem., June 21, 2002; 277(25): 22985 - 22991.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
F. Peiretti, S. Lopez, P. Deprez-Beauclair, B. Bonardo, I. Juhan-Vague, and G. Nalbone
Inhibition of p70S6 Kinase during Transforming Growth Factor-{beta}1/Vitamin D3-induced Monocyte Differentiation of HL-60 Cells Allows Tumor Necrosis Factor-{alpha} to Stimulate Plasminogen Activator Inhibitor-1 Synthesis
J. Biol. Chem., August 24, 2001; 276(34): 32214 - 32219.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T.-X. Liu, J.-W. Zhang, J. Tao, R.-B. Zhang, Q.-H. Zhang, C.-J. Zhao, J.-H. Tong, M. Lanotte, S. Waxman, S.-J. Chen, et al.
Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells
Blood, August 15, 2000; 96(4): 1496 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Niitsu, T. Kasukabe, A. Yokoyama, J. Okabe-Kado, Y. Yamamoto-Yamaguchi, M. Umeda, and Y. Honma
Anticancer Derivative of Butyric Acid (Pivalyloxymethyl Butyrate) Specifically Potentiates the Cytotoxicity of Doxorubicin and Daunorubicin through the Suppression of Microsomal Glycosidic Activity
Mol. Pharmacol., July 1, 2000; 58(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
Y. Kanatani, T. Kasukabe, J. Okabe-Kado, Y. Yamamoto-Yamaguchi, N. Nagata, K. Motoyoshi, and Y. Honma
Role of CD14 Expression in the Differentiation-Apoptosis Switch in Human Monocytic Leukemia Cells Treated with 1{{alpha}},25-Dihydroxyvitamin D3 or Dexamethasone in the Presence of Transforming Growth Factor {beta}
Cell Growth Differ., October 1, 1999; 10(10): 705 - 712.
[Abstract] [Full Text]


Home page
BloodHome page
N. Niitsu, Y. Yamaguchi, M. Umeda, and Y. Honma
Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2'-Deoxycoformycin and 2'-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3
Blood, November 1, 1998; 92(9): 3368 - 3375.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F.-h. Xu, S. Sharma, A. Gardner, Y. Tu, A. Raitano, C. Sawyers, and A. Lichtenstein
Interleukin-6-Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway
Blood, July 1, 1998; 92(1): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Makishima, K. Umesono, K. Shudo, T. Naoe, K. Kishi, and Y. Honma
Induction of Differentiation in Acute Promyelocytic Leukemia Cells by 9-cis Retinoic Acid alpha -Tocopherol Ester (9-cis Tretinoin Tocoferil)
Blood, June 15, 1998; 91(12): 4715 - 4726.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
F. Peiretti, S. Lopez, P. Deprez-Beauclair, B. Bonardo, I. Juhan-Vague, and G. Nalbone
Inhibition of p70S6 Kinase during Transforming Growth Factor-{beta}1/Vitamin D3-induced Monocyte Differentiation of HL-60 Cells Allows Tumor Necrosis Factor-{alpha} to Stimulate Plasminogen Activator Inhibitor-1 Synthesis
J. Biol. Chem., August 24, 2001; 276(34): 32214 - 32219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.